European Medicines Agency, Amsterdam, the Netherlands
The Committee for Advanced Therapies (CAT) is the committee that is responsible for assessing the quality, safety and efficacy of advanced-therapy medicines.
Documents
CAT monthly report of application procedures, guidelines and related documents on advanced therapies: January 2018
Reference Number: EMA/CAT/65887/2018Summary:
The CAT Monthly Report includes statistical data on CAT scientific recommendations on Advanced Therapy Medicinal Product (ATMP) classification, certifications, initial evaluations, CAT contributions to Scientific Advice and Paediatric Investigation Plans, as well as variations, line extensions, renewals.